SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $47,000 | +88.0% | 60,001 | +76.2% | 0.00% | – |
| Q1 2021 | $25,000 | -40.5% | 34,053 | +37.4% | 0.00% | – |
| Q4 2020 | $42,000 | -54.3% | 24,776 | -62.1% | 0.00% | – |
| Q3 2020 | $92,000 | -47.4% | 65,380 | -40.0% | 0.00% | -100.0% |
| Q2 2020 | $175,000 | +42.3% | 108,968 | -13.7% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | -95.4% | 126,321 | -93.9% | 0.00% | -90.0% |
| Q4 2019 | $2,671,000 | +16.2% | 2,070,000 | -31.0% | 0.01% | +11.1% |
| Q3 2019 | $2,298,000 | – | 3,000,000 | +455.6% | 0.01% | – |
| Q2 2019 | $0 | – | 540,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |